文献速递结核与非结核分枝杆菌

连续全国调查显示2007-2017年越南结核病负担下降

Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007-2017.
PubMed 文献 · Emerg Infect Dis · 2021-01-01

越南于2007年和2017年开展全国结核病患病率调查,采用问卷和胸部X线筛查,痰标本行涂片镜检和罗氏培养。培养阳性结核患病率下降37%,涂片阳性下降53%,涂片阴性无显著下降。建议以分子诊断替代镜检以进一步降低结核负担。

要点

  • 培养阳性结核患病率从199/10万降至125/10万,下降37%。
  • 涂片阳性结核患病率从99/10万降至46/10万,下降53%。
  • 涂片阴性结核患病率无显著下降,提示诊断缺口。

核心结论

  • 越南2007至2017年培养阳性和涂片阳性结核患病率显著下降,但涂片阴性结核无实质下降。

研究设计与样本

  • 越南于2007年和2017年开展两次全国结核病患病率调查,参与者均接受问卷和胸部X线筛查,痰标本行涂片镜检和罗氏培养。

主要发现

  • 培养阳性结核患病率从2007年199例/10万成人(95%CI 160-248)降至2017年125例/10万成人(95%CI 98-159),下降37%(95%CI 11.5%-55.4%)。
  • 涂片阳性结核患病率从99例/10万成人(95%CI 78-125)降至46例/10万成人(95%CI 32-68),下降53%(95%CI 27.0%-69.7%)。
  • 涂片阴性结核患病率无实质下降。

临床怎么用

  • 可考虑以分子诊断方法替代镜检作为初诊手段,以改善涂片阴性肺结核的诊断并进一步降低结核负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vietnam, a high tuberculosis (TB) burden country, conducted national TB prevalence surveys in 2007 and 2017. In both surveys participants were screened by using a questionnaire and chest radiograph; sputum samples were then collected to test for Mycobacterium tuberculosis by smear microscopy and Löwenstein-Jensen culture. Culture-positive, smear-positive, and smear-negative TB cases were defined by laboratory results, and the prevalence of tuberculosis was compared between the 2 surveys. The results showed prevalence of culture-positive TB decreased by 37% (95% CI 11.5%-55.4%), from 199 (95% CI 160-248) cases/100,000 adults in 2007 to 125 (95% CI 98-159) cases/100,000 adults in 2017. Prevalence of smear-positive TB dropped by 53% (95% CI 27.0%-69.7%), from 99 (95% CI 78-125) cases/100,000 adults to 46 (95% CI 32-68) cases/100,000 adults; smear-negative TB showed no substantial decrease. Replacing microscopy with molecular methods for primary diagnostics might enhance diagnosis of pulmonary TB cases and further lower TB burden.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Nguyen HV, Nguyen HB, Nguyen NV, et al. Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007-2017. Emerg Infect Dis. 2021. PMID: 33622491. doi:10.3201/eid2703.204253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。